These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20036073)

  • 1. Activation of central CRF receptor 1 by cortagine results in enhanced passive coping with a naturalistic threat in mice.
    Tovote P; Farrokhi CB; Gonzales RM; Schnitzbauer U; Blanchard DC; Blanchard RJ; Spiess J
    Psychoneuroendocrinology; 2010 Jul; 35(6):887-95. PubMed ID: 20036073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways.
    Larauche M; Gourcerol G; Wang L; Pambukchian K; Brunnhuber S; Adelson DW; Rivier J; Million M; Taché Y
    Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G215-27. PubMed ID: 19407218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortagine: behavioral and autonomic function of the selective CRF receptor subtype 1 agonist.
    Farrokhi CB; Tovote P; Blanchard RJ; Blanchard DC; Litvin Y; Spiess J
    CNS Drug Rev; 2007; 13(4):423-43. PubMed ID: 18078427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortagine infused into the medial prefrontal cortex attenuates predator-induced defensive behaviors and Fos protein production in selective nuclei of the amygdala in male CD1 mice.
    Pentkowski NS; Tovote P; Zavala AR; Litvin Y; Blanchard DC; Spiess J; Blanchard RJ
    Horm Behav; 2013 Aug; 64(3):519-26. PubMed ID: 23845323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model.
    Tezval H; Jahn O; Todorovic C; Sasse A; Eckart K; Spiess J
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9468-73. PubMed ID: 15192151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine.
    Todorovic C; Jahn O; Tezval H; Hippel C; Spiess J
    Neurosci Biobehav Rev; 2005; 29(8):1323-33. PubMed ID: 16099044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRF type 1 receptors in the dorsal periaqueductal gray modulate anxiety-induced defensive behaviors.
    Litvin Y; Pentkowski NS; Blanchard DC; Blanchard RJ
    Horm Behav; 2007 Aug; 52(2):244-51. PubMed ID: 17540371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
    Sherrin T; Todorovic C; Zeyda T; Tan CH; Wong PT; Zhu YZ; Spiess J
    Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats.
    Zhao Y; Valdez GR; Fekete EM; Rivier JE; Vale WW; Rice KC; Weiss F; Zorrilla EP
    J Pharmacol Exp Ther; 2007 Dec; 323(3):846-54. PubMed ID: 17855476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
    Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
    Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes.
    Sahuque LL; Kullberg EF; Mcgeehan AJ; Kinder JR; Hicks MP; Blanton MG; Janak PH; Olive MF
    Psychopharmacology (Berl); 2006 May; 186(1):122-32. PubMed ID: 16568282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice.
    Martínez V; Wang L; Rivier J; Grigoriadis D; Taché Y
    J Physiol; 2004 Apr; 556(Pt 1):221-34. PubMed ID: 14755002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
    Miguel TT; Nunes-de-Souza RL
    Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acidic-astressin and ovine-CRF microinfusions into the ventral hippocampus on defensive behaviors in rats.
    Pentkowski NS; Litvin Y; Blanchard DC; Vasconcellos A; King LB; Blanchard RJ
    Horm Behav; 2009 Jun; 56(1):35-43. PubMed ID: 19269291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress.
    Pelleymounter MA; Joppa M; Ling N; Foster AC
    J Pharmacol Exp Ther; 2002 Jul; 302(1):145-52. PubMed ID: 12065711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tonic modulation of anxiety-like behavior by corticotropin-releasing factor (CRF) type 1 receptor (CRF1) within the medial prefrontal cortex (mPFC) in male mice: role of protein kinase A (PKA).
    Miguel TT; Gomes KS; Nunes-de-Souza RL
    Horm Behav; 2014 Jul; 66(2):247-56. PubMed ID: 24848364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Region specific gene expression profile in mouse brain after chronic corticotropin releasing factor receptor 1 activation: the novel role for diazepam binding inhibitor in contextual fear conditioning.
    Sherrin T; Blank T; Saravana R; Rayner M; Spiess J; Todorovic C
    Neuroscience; 2009 Aug; 162(1):14-22. PubMed ID: 19362130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats.
    Korte SM; Korte-Bouws GA; Bohus B; Koob GF
    Physiol Behav; 1994 Jul; 56(1):115-20. PubMed ID: 8084889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
    Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
    Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress.
    Henry B; Vale W; Markou A
    J Neurosci; 2006 Sep; 26(36):9142-52. PubMed ID: 16957071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.